Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine
NCT00554333
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
795
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Flu-ID 15μg
BIOLOGICAL:
Inactivated adjuvanted Influenza Vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company